HLA-E Protects Glioma Cells from NKG2D-Mediated Immune Responses In Vitro: Implications for Immune Escape In Vivo

10.1146/annurev.immunol.22.012703.104803

10.1016/0165-0173(95)00010-0

10.1126/science.285.5428.727

Friese, 2003, MICA/NKG2D-mediated immunogene therapy of experimental gliomas, Cancer Res, 63, 8996

10.1158/0008-5472.CAN-04-1627

10.1146/annurev.immunol.16.1.359

10.1385/IR:30:1:029

10.1038/35869

10.1073/pnas.95.9.5199

10.1093/emboj/18.15.4250

10.1002/eji.1830270517

10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y

10.4049/jimmunol.171.3.1376

Ulbrecht, 1992, The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein, J Immunol, 149, 2945, 10.4049/jimmunol.149.9.2945

10.1038/ni1063

Marin, 2003, Analysis of HLA-E expression in human tumors, Immunogenetics, 54, 767, 10.1007/s00251-002-0526-9

10.1172/JCI200215564

10.1038/sj.onc.1207198

10.1016/0008-8749(92)90322-G

Robertson, 1996, Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia, Exp Hematol, 24, 406

10.1038/35078107

10.4049/jimmunol.168.9.4772

10.1073/pnas.0730640100